Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Three cost-effective methods accurately measure finasteride in pharmaceuticals, better than current techniques.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Apremilast shows promise for several skin conditions but needs more research.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Created method to measure doxazosin mesylate and finasteride together.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

The man's fatigue and erectile dysfunction were improved by treating his obesity-related low testosterone without needing testosterone replacement.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Using old drugs for new uses can help treat rare immune deficiencies.

Canine hair follicles have stem cells similar to human hair follicles, useful for studying hair disorders.

Hair treatments and dehydration affect hair's lipid and protein behavior, influencing its flexibility and appearance.

Hair follicle-derived extracellular vesicles may help heal chronic wounds as effectively as those from adipose tissue.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Bird foot scales develop differently and can repair but not fully regenerate due to the lack of specialized stem cell areas.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Taking spironolactone doesn't increase the chance of breast cancer coming back.